CS logo
small CS logo
Vanderbilt University Oncology Pharmacy

Nashville, Tennessee, United States
Pharmacy in Nashville, Tennessee
1301 Medical Center Dr Suite 1815, Nashville, TN 37212

About Vanderbilt University Oncology Pharmacy


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Vanderbilt University Oncology Pharmacy


During the past decade, Vanderbilt University Oncology Pharmacy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt University Oncology Pharmacy" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Vanderbilt University Oncology Pharmacy


According to Clinical.Site data, the most researched conditions in "Vanderbilt University Oncology Pharmacy" are "Advanced Cancer" (1 trials), "Non Squamous Lung Cancer" (1 trials), "Renal Cell Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Vanderbilt University Oncology Pharmacy" in a lesser frequency.

Clinical Trials Intervention Types at Vanderbilt University Oncology Pharmacy


Most popular intervention types in "Vanderbilt University Oncology Pharmacy" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (1 trials), "Avelumab (MSB0010718C)" (1 trials), "Axitinib" (1 trials), "Axitinib (AG-013736)" (1 trials) and "CMP-001" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Vanderbilt University Oncology Pharmacy


The vast majority of trials in "Vanderbilt University Oncology Pharmacy" are 4 trials for "All" genders.

Clinical Trials Status at Vanderbilt University Oncology Pharmacy


Currently, there are NaN active trials in "Vanderbilt University Oncology Pharmacy". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Vanderbilt University Oncology Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Vanderbilt University Oncology Pharmacy, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".